کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
8926254 | 1643667 | 2018 | 17 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Traitement médical de l'endométriose : prise en charge de la douleur et de l'évolution des lésions par traitement hormonal. RPC Endométriose CNGOF-HAS
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
Analogues de la GnRHLNG IUSEstroprogestatifsQuality of life - کیفیت زندگیGnRH analogs - آنالوگ GnRHEndometriose - آندومتریوزEndometriosis - اندومتریوزRécidive - تکرار جنایاتPain - دردDouleur - دردCombined oral contraceptives - ضد بارداری خوراکی ترکیبیRecurrence - عودProgestatifs - پروژسترونProgestins - پروژستینqualité de vie - کیفیت زندگی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
زنان، زایمان و بهداشت زنان
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
The available literature, from 2006 to 2017, on hormonal treatment has been analysed as a contribution to the HAS-CNGOF task force for the treatment of endometriosis. Available data are heterogeneous and the general level of evidence is moderate. Hormonal treatment is usually offered as the primary option to women suffering from endometriosis. It cannot be used in women willing to conceive. In women who have not been operated, the first line of hormonal treatment includes combined oral contraceptives (COC) and the levonorgestrel-releasing intra uterine system (52Â mg LNG-IUS). As a second line, desogestrel progestin only pills, etonogestrel implants, GnRH analogs (GnRHa) with add back therapy and dienogest can be offered. Add back therapy should include estrogens to prevent bone loss and improve quality of life, it can be introduced before the third month of treatment to prevent side effects. The literature does not support preoperative hormonal treatment for the sole purpose of reducing complications or recurrence, or facilitating surgical procedures. After surgical treatment, hormonal treatment is recommended to prevent pain recurrence and improve quality of life. COCs or LNG IUS are recommended as a first line. To prevent recurrence of endometriomas COC is advised and maintained as long as tolerance is good in the absence of pregnancy plans. In case of dysmenorrhea, postoperative COC should be used in a continuous scheme. GnRHa are not recommended in the sole purpose of reducing endometrioma recurrence risk.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Gynécologie Obstétrique Fertilité & Sénologie - Volume 46, Issue 3, March 2018, Pages 231-247
Journal: Gynécologie Obstétrique Fertilité & Sénologie - Volume 46, Issue 3, March 2018, Pages 231-247
نویسندگان
S. Geoffron, J. Cohen, M. Sauvan, G. Legendre, J.M. Wattier, E. Daraï, H. Fernandez, N. Chabbert-Buffet,